UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 265

Sortiert nach

HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors

PloS one, 2012-07, Vol.7 (7), p.e39652-e39652

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence

Journal of hepatology, 2011-09, Vol.55 (3), p.587-593

2011

Link zum Volltext

Verfügbarkeit prüfen

Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension

Digestive diseases and sciences, 2018-01, Vol.63 (1), p.264-267

2018

Link zum Volltext

Verfügbarkeit prüfen

Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant

Annals of hepatology, 2021-05, Vol.22, p.100162-100162, Article 100162

2021

Link zum Volltext

Verfügbarkeit prüfen

Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort

Annals of hepatology, 2021-09, Vol.24, p.100309-100309, Article 100309

2021

Link zum Volltext

Verfügbarkeit prüfen

The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10‐year follow‐up

Transplant international, 2013-03, Vol.26 (3), p.259-266

2013

Link zum Volltext

Verfügbarkeit prüfen

Short-Term, Low-Dose Use of Tolvaptan as a Bridge Therapy to Expedite Liver Transplant for Severe Hyponatremic, Cirrhotic Patients With High Model for End-Stage Liver Disease Scores

Experimental and clinical transplantation, 2017-12, Vol.15 (6), p.689-692

2017

Link zum Volltext

Verfügbarkeit prüfen

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

PloS one, 2017-05, Vol.12 (5), p.e0177352

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

BMC infectious diseases, 2018-05, Vol.18 (1), p.223-223, Article 223

2018

Link zum Volltext

Verfügbarkeit prüfen

TACE vs DEB-TACE: Who wins?

Digestive and liver disease, 2016-07, Vol.48 (7), p.796-797

Angelico, Mario

2016

Link zum Volltext

Verfügbarkeit prüfen

Domino Liver Transplantation: Where are we Now?

Reviews on recent clinical trials, 2019-01, Vol.14 (3), p.183

2019

Link zum Volltext

Verfügbarkeit prüfen

Morphological and Functional Features of Hepatic Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease

The American journal of pathology, 2008-02, Vol.172 (2), p.321-332

2008

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B

Antiviral therapy, 2009-11, Vol.14 (8), p.1165-1174

2009

Link zum Volltext

Verfügbarkeit prüfen

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study

Annals of hepatology, 2019-05, Vol.18 (3), p.434-438

2019

Link zum Volltext

Verfügbarkeit prüfen

Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b

Viruses, 2021-04, Vol.13 (5), p.743

2021

Link zum Volltext

Verfügbarkeit prüfen

Liver Contrast Enhanced Ultrasound Perfusion Imaging in the Evaluation of Chronic Hepatitis C Fibrosis: Preliminary Results

Ultrasound in medicine & biology, 2011, Vol.37 (1), p.1-6

2011

Link zum Volltext

Verfügbarkeit prüfen

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient

Radiology case reports, 2020-12, Vol.15 (12), p.2602-2606

2020

Link zum Volltext

Verfügbarkeit prüfen

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

Hepatology (Baltimore, Md.), 2002, Vol.35 (1), p.176-181

2002

Link zum Volltext

Verfügbarkeit prüfen

The evolving scenario of HBV infection and disease: A never-ending story

Digestive and liver disease, 2019-03, Vol.51 (3), p.443-444

2019

Link zum Volltext

Verfügbarkeit prüfen

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection

Emerging microbes & infections, 2020-01, Vol.9 (1), p.928-939

2020

Link zum Volltext

Verfügbarkeit prüfen

Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis

Digestive and liver disease, 2010-08, Vol.42 (8), p.578-584

2010

Link zum Volltext

Verfügbarkeit prüfen

Switch to 1.5 grams MMF monotherapy for CNI‐related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension

Liver transplantation, 2007-01, Vol.13 (1), p.46-54

2007

Link zum Volltext

Verfügbarkeit prüfen

Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha

Hepatology (Baltimore, Md.), 2002-05, Vol.35 (5), p.1041-1052

2002

Link zum Volltext

Verfügbarkeit prüfen

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets

Viruses, 2018-07, Vol.10 (7), p.363

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 265

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(252)

Publikationsform

Artikel
(247)
Buchkapitel
(14)
Bücher
(2)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors

Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence

Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension

Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant

Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort

The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10‐year follow‐up

Short-Term, Low-Dose Use of Tolvaptan as a Bridge Therapy to Expedite Liver Transplant for Severe Hyponatremic, Cirrhotic Patients With High Model for End-Stage Liver Disease Scores

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

TACE vs DEB-TACE: Who wins?

Domino Liver Transplantation: Where are we Now?

Morphological and Functional Features of Hepatic Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease

A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B

Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro

Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b

Liver Contrast Enhanced Ultrasound Perfusion Imaging in the Evaluation of Chronic Hepatitis C Fibrosis: Preliminary Results

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

The evolving scenario of HBV infection and disease: A never-ending story

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection

Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis

Switch to 1.5 grams MMF monotherapy for CNI‐related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension

Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets

Suchergebnisse filtern